For Family and Friends
Safety Information
 

Friends

Emotional Support

All of the emotions and symptoms your loved one experiences may affect the way he or she acts. While some people may not express their frustrations and anger, others will. This anger may be misdirected toward family members, friends, healthcare professionals, or you. It is important to remember the reasons for the anger. And show that you understand.

Giving emotional support is a natural way to help your loved one. But at times, it may also be a challenge. The following tips may help:

  • Talk with your loved one. Let him or her know you are there to help
  • Listen to your loved one. Help him or her work through many feelings he or she may be having. It is important to provide hope, comfort, and encouragement
  • Meet other patients or caregivers who are dealing with CLL. They can help provide information, comfort, and hope. Click here for a list of cancer organizations. Some of them can connect you with others who are living with CLL
Next Section Caregiver Resources

Indications

RITUXAN® (Rituximab) is indicated in combination with fludarabine and cyclophosphamide (FC chemotherapy) for the treatment of patients with:

  • Previously untreated CD20-positive CLL
  • Previously treated CD20-positive CLL

People with serious infections should not receive RITUXAN.

Safety Information

  • RITUXAN can cause serious side effects that can lead to death, including: infusion reactions, tumor lysis syndrome (TLS; kidney failure due to fast breakdown of cancer cells), severe skin and mouth reactions, and progressive multifocal leukoencephalopathy (PML; a rare, serious brain infection).
  • RITUXAN has also been associated with serious and life-threatening side effects, including: the return of active hepatitis B virus infection with sudden and serious liver problems including liver failure, and death, other serious infections that can lead to death, heart problems, kidney problems, and stomach and serious bowel problems including blockage and tears in the bowel that can sometimes lead to death.
  • The most common side effects of RITUXAN seen in clinical trials of patients with CLL were infusion reactions and low white blood cells, which can increase the risk of infections. Before starting treatment with RITUXAN it is important for you to talk to your doctor about your medical history.
  • Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects with RITUXAN. For more information, ask your doctor.

Please see full Prescribing Information, including Medication Guide, in PDF format.